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Summary 
Activated macrophages (Mcks) are important participants in host defense, but their uncontrolled 
activation leads rapidly to septic shock and death. One mechanism for regulating other dan- 
gerous cells in the immune system is programmed cell death, or apoptosis. Monocytes are known 
to undergo spontaneous apoptosis upon leaving the circulation unless provided with specific sur- 
vival signals, but mature tissue Mcks are more robust cells, and it was not dear that they could 
be similarly regulated by apoptosis. We now show that during differentiation monocytes rapidly 
lose their sensitivity to apoptosis triggered by passive cytokine withdrawal, but they may retain 
a novel pathway which initiates  apoptosis after activation with specific stimuli  (zymosan  and 
phorbol esters). Sensitivity to activation-induced apoptosis was developmentally determined, being 
downregulated by the maturation-promoting cytokine macrophage  colony-stimulating factor 
but stably upregulated by even transient  exposure to the proinflammatory cytokine interferon 
3' (IFN-'y). Apoptosis began within 2~-4 h of activation, occurred in >95% of susceptible cells, 
and in mixed cocultures sdectively affected only those M~bs with a history of IFN-'~ priming. 
Consistent  with a possible role for protein kinase C in the signaling pathway leading to cell 
death, the kinase inhibitor staurosporine was protective against both phorbol ester- and zymosan- 
induced apoptosis. Our studies describe a novel form of activation-induced Mck apoptosis which 
is developmentally regulated by two physiologically relevant cytokines. We speculate that apop- 
tosis may serve to restrict  the destructive  potential of inflammatory Mq~s. 
T 
issue  macrophages  (M~s) 1,  once  regarded  princi- 
pally as scavengers and accessory cells, are now recog- 
nized as pivotal regulators  of inflammation and immunity 
(1, 2). In addition, they are the principal effector cells against 
a broad class of facultative intraceUular pathogens, including 
clinically important mycobacteria, fungi, and protozoa (3). 
To eliminate these highly resistant microorganisms, M~s must 
be "primed" by proinflammatory cytokines, in particular the 
T  cell-derived lymphokine  IFN-'y  (4). Although  IFN- 
y-primed Mcks are crucial for host defense (5, 6), they are 
also dangerous cells because of their production of free rad- 
icals, lytic enzymes, and inflammatory cytokines (7). These 
can cause extensive local damage, and are responsible for many 
of the systemic symptoms associated with acute and chronic 
inflammation (8). If uncontrolled, M~k activation leads to the 
1  Abbreviations used in this paper: MCSF, macrophage colony-stimulating 
factor; M~s, macrophages; NO, nitric oxide; PKC, protein kinase C; rh, 
recombinant human; TdT, terminal deoxytransferase. 
clinical syndrome of septic shock and ultimately to the death 
of the host (8, 9). 
These dangers suggest that activated M~ks must be subject 
to strict regulatory control. One mechanism known to regulate 
other potentially  dangerous cells in the immune system is 
programmed cell death, or apoptosis (reviewed in reference 
10). This phenomenon has been most extensively studied in 
the lymphoid lineage, where autoreactive thymocytes undergo 
activation-induced  apoptosis upon encountering "self" an- 
tigens in the thymus (11), but apoptosis also appears to play 
an important role in limiting the persistence of activated T 
cells (12, 13), B cells (14, 15), and granulocytes (16). Thus, 
apoptosis would seem a logical candidate to participate  in 
M~ regulation as well. 
Consistent with this hypothesis, studies by Mangan et al. 
(17, 18) have shown that the precursor  cells for M~ks, cir- 
culating monocytes, spontaneously undergo apoptosis unless 
given "permission" to survive by inflammatory mediators or 
growth factors. However, as circulating monocytes differen- 
tiate into mature Mcks they become robust, long-lived cells, 
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apoptotic stimuli as antineoplastic agents and ionizing radia- 
tion (19). Thus, it was not clear that mature M~s were sub- 
ject to apoptosis in the same fashion as fresh monocytes. 
In this report we examine the regulation of  apoptosis during 
the process  of in  vitro  differentiation from monocyte to 
monocyte-derived M~s (henceforward referred  to as M~bs). 
We used a defined model using the maturation-promoting 
cytokine macrophage colony-stimulating  factor (MCSF) and 
the inflammatory  cytokine IFN-3'. We have previously shown 
that the interaction of these two agents during differentia- 
tion markedly affects the phenotype and function of the resul- 
tant M~bs (20).  In this study we asked (a) whether mature 
MCs, like fresh monocytes, remained dependent on permis- 
sive cytokines for continued survival; (b) if not, whether the 
mature M~s possessed an inducible apoptosis pathway; and 
(c) whether the cytokine environment present during differen- 
tiation influenced the susceptibility of Mq~s to apoptosis. 
Materials and Methods 
Cytoh'nes and Reagents.  Recombinant  human MCSF (rhMCSF), 
sp act 1.65  x  106 U/mg protein by mouse bone marrow colony 
assay, was the gift of Genetics Institute, Inc. (Cambridge, MA). 
rhlFN-3,,  1.8  x  107 U/mg protein, was the gift of Genentech 
(South San Francisco,  CA). Both cytokines contained <0.03 endo- 
toxin U/ml by limulus amebocyte  lysate assay (Associates of Cape 
Cod, Inc., Woods Hole, MA) at 10x  the working dilutions used. 
Staurosporine (Sigma Chemical Co., St. Louis, MO) was prepared 
as a 10,O00x stock in ethanol. All other reagents were obtained 
from Sigma Chemical Co. unless otherwise specified. 
Isolation and Culture of  Human Monocytes.  PBMC  were obtained 
by leukocytapheresis  of  volunteer donors under a protocol approved 
by our Institutional Review Board. Monocytes were isolated ei- 
ther by sequential centrifugation over Ficoll-Hypaque and hyper- 
tonic Percoll as previously described (20), or by counterflow cen- 
trifugal elutriation (modified from reference 21). These cells were 
either used immediately or cryopreserved  in liquid nitrogen. Fresh 
and frozen monocytes  behaved  indistinguishably in our system  and 
have been used interchangeably  in our recent reports (20, 22, 23). 
Final monocyte purification was accomplished by adherence to 
serum-coated plastic as described (24). The adherent population 
was reproducibfly  >95% monocytes  by Wright's stain morphology 
and CD11c expression. 
For monocyte culture our minimal medium consisted of RPMI 
1640 (GIBCO BRL, Gaithersburg, MD) with penicillin, strepto- 
mycin, and 2 mM glutamine. Except for cytokine withdrawal ex- 
periments, this  basal medium was routinely supplemented  with 10% 
bovine calf serum (Hyclone Laboratories, Inc., Logan, UT) and 
200 U/ml rhMCSF. All media and reagents contained <0.03 U/ml 
endotoxin. 
Derivation of the MCSF and IFN-9, Me Phenotypes.  To model 
monocyte differentiation in vitro we used our previously  described 
system of long-term culture in rhMCSF (24). To derive the con- 
trasting IFN-qc-primed  phenotype, we added 100 U/ml IFN-qr plus 
rhMCSF (even with IFN-'r  M~bs  require MCSF for long-term sur- 
vival). In this report we refer to these two phenotypes as MCSF- 
type and IFN-3'-type M~s. We have previously shown that essen- 
tially all of the starting monocytes survive for >7 d in our system 
(20), so the emergence of different phenotypes reflects alternative 
maturation pathways rather  than selective survival of particular 
subpopulations. 
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Activation of Mes.  M~bs  were activated with serum-opsonized 
zymosan (20 #g/ml, prepared as described by Pick [25]), FMLP 
(10 #M),  LPS (100 ng/ml), antibody-coated microparticles (Ad- 
vanced Magnetics, Inc.,  Cambridge,  MA),  PMA  (50  ng/ml), 
thymeteatoxin (l/g) ng/ml; LC Laboratories, Woburn, MA), and 
the inactive  phorbol ester 4ot-phorbol 12,13 didecanoate  (50 ng/ml). 
Each agent was screened for evidence  of  biologic effect in our cells, 
defined as either respiratory burst by nitroblue tetrazolium reduc- 
tion (25), adherence and spreading on serum-coated substrate, or 
phagocytosis of the stimulus. Each agent triggered at least one of 
these responses, with  the  exception of the  4c~-phorbol 12,13 
didecanoate negative control. 
Assessment of  Me Survival.  Mq~s  undergoing activation-induced 
apoptosis progressed rapidly to secondary necrosis (see Fig. 3), 
leaving only cellular debris by 24 h. In experiments where only 
end-point data were required survival was assessed by phase con- 
trast microscopy  and trypan blue dye exclusion.  Where precise quan- 
titation of surviving cells was important we measured the DNA 
content in adherent  M~b monolayers  by the dye-fluorescence  method 
of Downs and Wilfinger (26). This technique had the important 
advantage that fusion of individual cells into multinucleated giant 
cells would not be falsely  interpreted as cell death. The results from 
this assay were always confirmed qualitatively by phase contrast 
microscopy or trypan blue dye exclusion, with good agreement. 
Assessment of  Apoptosis.  Internucleosomal  DNA fragmentation 
was assessed using a whole-cell lysate technique as described by 
Zakeri et al. (27). Briefly, 2-3  x  106 cells were lysed (1% SDS, 
100 mM NaC1, 1 mM EDTA, 10 mM Tris, pH 7.4), treated with 
0.2 mg/ml proteinase K for 1 h at 56~  followed by 500 U/ml 
DNAse-free RNAse (Sigma Chemical Co.) for 1 h at 37~  then 
electrophoresed  in a 1.5% agarose, Tris-borate-EDTA  gel and stained 
with ethidium bromide. The THP-1 human macrophage-like cell 
line (American Type  Culture Collection, Rockville, MD), induced 
to undergo apoptosis by exposure to 5/zg/ml actinomycin D or 
200 nM stanrosporine, was used as a positive control. 
To detect DNA fragmentation in individual cells we used an 
in situ nick/end-labeling technique similar to that of Gavrieli et 
al. (28), based on incorporation of  digoxigenin-labeled  nucleotides 
at sites of DNA strand breaks by terminal deoxytransferase  (TdT) 
(Apoptag; Oncor Inc., Gaithersburg, MD). Cytocentrifuge slides 
were prepared and processed as described  in the manufacturer's  pro- 
tocol. Incorporated label was detected using fluorescein-conjugated 
antidigoxigenin  antibody.  Negative  controls were processed without 
TdT; positive controls were pretreated for 5 rain with 1,000 U/ml 
deoxyribonuclease  I, which produced intense labeling of all nuclei. 
Loss of DNA from apoptotic nuclei was quantitated by flow 
cytometry (29). M~bs were activated  with either zymosan or PMA 
as described. After 24 h to allow for loss of fragmented  DNA, nuclei 
were released from the cells by treatment with 1% Triton X-100 
in 0.1 M citric acid, stained with 10/~g/ml propidium iodide, and 
analyzed by flow cytometry. 
For ultrastructural studies, monocytes were cultured for 4 d in 
rhMCSF  +  IFN-  7 then exposed to 50 ng/ml PMA for 0, 2, or 
4 h, harvested, and fixed in 2% glutaraldehyde for transmission 
electron microscopy. 
Assays  for Reactive lntermediates of Oxygen and Nitrogen.  Hydro- 
gen peroxide  production was quantitated as the peroxidase-catalyzed 
extinction of scopoletin fluorescence  measured against a standard 
curve of reagent H202, after the method of Nathan  and Root 
(30). Superoxide production was determined spectrophotometri- 
call)' as oxidation of ferricytochrome c, after the method of Pick 
(25). Nitric oxide (NO) production was assayed  as nitrite forma- 
tion by the diaminonaphthalene fluorescence  method of Damiani 
and Burdini (31) as previously described (32); this assay had a de- 
Apoptosis tection limit in our hands of 30 pmol nitrite. The complete lack 
of NO  production in our system seen with  this technique was 
confirmed using a sensitive bioassay (induction of guanidyl cyelase 
activity in cultured smooth muscle cells after coculture with acti- 
vated M~s,  generously performed for us by N.  Marczin and J. 
Catravas  using their published protocol [33]). 
Scavengers and inhibitors of reactive oxygen species were used 
at the highest concentration determined in preliminary titration 
experiments to be nontoxic to the cells (individual agents and con- 
centrations are given in Results). Each agent was added I h before 
the addition of PMA, except for N-acetylcysteine  which was added 
3 h before permit incorporation into the intracellular thiol pool. 
PKH26 Labeling  and Coculture.  Stably apoptosis-sensitive  Mcks 
were derived by exposing monocytes to rhMCSF +  IFN-3, for 24 h. 
These cultures were then washed and continued in rhMCSF alone 
for 3 d. Apoptosis-resistant M#s were derived by culturing mono- 
cytes in rhMCSF alone for 4 d. The MCSF-type cells were then 
detached from their culture dishes with 2 mM EDTA as previously 
described (22), labeled with the tracking dye PKH26 (Zynaxis Cell 
Science, Malvern, PA) according to the manufacturer's protocol, 
mixed 1:1 with IFN-q'-type cells (also harvested with EDTA), and 
the combined cell suspension  replated and activated with PMA. 
After 24 h  the cocultures were harvested and analyzed by flow 
cytometry. Preliminary experiments had documented that PKH26 
labeling did not affect the survival or sensitivity to apoptosis  of 
either cell type, and that the dye did not transfer from labded to 
unlabeled cells. The cells recovered from cocultures were counted, 
and the absolute number of each cell type calculated based on the 
flow cytometry analysis. 
BCL-2 Analysis.  M~s were harvested with EDTA as described 
above. Expression of BCL-2 protein was  assessed by flow cytom- 
etry using fluorescein-conjugated mAb 124 (34) from Dako Corp. 
(Carpinteria, CA), as described by Tamaru et al. (35). Peripheral 
blood lymphocytes were used as positive controls; isotype-matched 
irrelevant mAb was used as a negative control. Immunoblots were 
prepared by Laemmli SDS-PAGE followed by electrophoretic transfer 
to polyvinyl difluoride membranes (36). Blots were blocked (3% 
goat serum in 0.1 M NaC1, 0.1% Tween-20, 10 mM Tris, pH 7.5), 
incubated  with  mAb  124,  and  developed with  a  commercial 
peroxidase-based  chemiluminescence  system  (ECL;  Amersham 
Corp.,  Arlington Heights,  IL). 
Protein  Kinase C Assays.  Enzymatic activity consistent with pro- 
tein kinase (PKC) was  defined as Ca  ~§  dependent phos- 
phorylation of  a PKC-selective polypeptide substrate (37) based on 
residues 4-14 of myelin basic protein (MBP~-14; LC Laboratories). 
After exposure to PMA for 15 min at 37~  cells were separated 
into soluble  and particulate fractions by sonication and ultracen- 
trifugation (100,000 g  x  15 min), and kinase  activity measured 
as previously described  (38). Activity associated with the particu- 
late fraction was  assayed without detergent extraction. 
For immunoblots, nuclei were isolated  by treatment of whole 
cells on ice with 1% Triton X-100 in 0.15 M  NaC1,  10 mM so- 
dium phosphate, pH 7.4, with inhibitors of proteases  and phos- 
phatases  (39).  After 10 s the detergent was diluted with ice-cold 
buffer to minimize extraction of PKC, and the nuclei pelleted and 
washed.  Nuclear  and  nonnuclear  fractions  were  transferred  to 
Laemmli sample buffer and immunoblots performed using affinity- 
purified polyclonal antibody against  the c~ isoform of PKC, pre- 
pared as described  (40), followed by detection with l~SI-protein  A. 
Statistical Analysis.  In most experiments apoptosis was a uni- 
form,  "all-or-none" phenomenon  and  differences  were  evident 
without statistical  analysis, pre- and postactivation samples were 
compared by paired t test. Titrations were compared by one-way 
analysis of  variance. In all figures error bars reflect standard deviation. 
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Results 
Differentiating Mq~s  Become Resistant to Cytokine Withdrawal. 
As expected from previous reports (17), we found that fresh 
monocytes cultured in  the  absence  of serum  or activating 
factors rapidly lost viability (<20%  surviving at 48 h) and 
displayed the light-microscopic features of apoptosis.  How- 
ever, as monocytes differentiated in response to rhMCSF they 
became increasingly indifferent to cytokine withdrawal (Fig. 
1 A),  such that by day 4  they no longer required serum or 
any exogenous growth factors for long-term survival. If IFN-~ 
was present  (Fig.  1 A),  monocytes became independent  of 
cytokines even more rapidly (within 24 h). Mature M#s not 
only survived without growth factors but remained function- 
ally active, as indicated by the respiratory burst shown in Fig. 
1R 
Activation of  lFN-7-type MC~s Triggers  Cell Death.  We next 
activated MCSF-type and IFN-q,-type M~s with a panel of 
standard agents induding LPS, FMLP, serum-opsonized zy- 
mosan, antibody-coated micropartides, and PMA. Both types 
of M#s responded to each agent with the expected evidence 
of activation (see Materials and Methods),  and none of the 
stimuli affected viability in short-term assays (1-2 h). How- 
ever, in the case of IFN-q,-type M~s,  activation with  two 
agents, PMA or opsonized zymosan, resulted in the uniform 
Figure 1.  Differentiating  M~s become  resistant to cytokine  withdrawal. 
(.,4) Fresh monocytes  were exposed  to rhMCSF alone (circles)  or rhMCSF 
+  IFN-7 (squares) for the times indicated, then washed and continued 
in minimal medium without serum or cytokines.  Survival  was quantitated 
on day 7 as the DNA content of the adherent cell monolayer,  expressed 
as a percentage  of  controls  (monocytes  cultured with serum and cytokines). 
Each point is the mean of triplicate measurements; SD were all less than 
+10%. Representative  of three experiments. (B) Monocytes exposed to 
rhMCSF +  IFN-3, for 24 h then continued for 4 d in minimal medium 
retained  an active  respiratory  burst (shown as nitroblue tetrazolium reduc- 
tion, dark reaction product). -2 
w  L~ 
rr~ 
100 
75 
50 
25 
0 
6  12  18  24 
TIME AFTER STIMULATION (h) 
Figure  2.  Activation of M~s 
primed with  IFN-3, results in 
rapid cell  death. Monocytes  were 
cultured for 4 d in rhMCSF  + 
IFN-3', and viability  was assessed 
by trypan blue dye exclusion  after 
activation with PMA or zymosan 
(both agents gave  similar results). 
Each point represents the average 
of  data from at least three  separate 
experiments. Points marked  with 
an asterisk are significantly  differ- 
ent from the baseline  value  by one- 
way analysis  of  variance (p <0.05). 
and progressive death of >95%  of cells within  24 h  of ex- 
posure (Fig. 2). Activation-induced cell death occurred only 
in IFN-3,-type M~s; MCSF-type Mq~s responded identically 
to the activating agents but did not go on to die (discussed 
further in Fig. 5, below). The lethal effect of activation on 
IFN-'y-type M<ks was reproducible in >120 experiments with 
14 donors, with no negative experiments  observed to date. 
Activation-induced Cell Death Occurs via Apoptosis.  We next 
asked whether the death of IFN-3,-type M~bs was associated 
with the oligonucleosomal DNA cleavage which accompa- 
nies apoptosis in many systems (41).  As shown in Fig. 3 A, 
we found little evidence of oligonucleosomal fragmentation 
in  dying  M~ks compared  to  our  positive controls  (THP-1 
leukemia cells treated with actinomycin D or staurosporine). 
A modest oligonucleosomal pattern could be demonstrated 
if low molecular weight DNA was selectively enriched be- 
fore electrophoresis (e.g.,  as described in reference 17), but 
we were unsure that this minor population constituted a bio- 
logically significant indicator of apoptosis (for this reason, 
data not  shown). 
However, it has recently been shown that low molecular 
weight DNA fragments may not be generated during apop- 
toffs (27), despite the presence of extensive high molecular 
weight DNA fragmentation and other characteristic changes 
of apoptosis (42).  We therefore turned  to three additional 
techniques for detecting apoptosis: in situ labeling of DNA 
strand breaks by the enzyme TdT (28),  quantitative loss of 
fragmented DNA from individual nuclei measured by flow 
cytometry (29), and the hallmark ultrastructural changes (43). 
As shown in Fig. 3 B, TdT labeling revealed extensive and 
progressive DNA strand breaks beginning 1-2 h after activa- 
tion, at a time when the cells still uniformly retained mem- 
brane integrity by trypan blue dye exclusion (Fig.  2).  The 
onset of DNA fragmentation  in individual  cells was asyn- 
chronous, but by 4-5 h after activation 80-90% of cells were 
either TdT positive or had progressed to secondary necrosis. 
When nuclear DNA content was quantitated by propidium 
iodide staining (Fig. 3 C) a prominent hypodiploid peak was 
evident in the PMA-activated cells,  consistent  with loss of 
low molecular weight DNA and formation of micronuclei 
Figure  3.  DNA fragmentation during M<k apoptosis. Mcks cultured in IFN-y were exposed to PMA for 5 h, then harvested for DNA analysis. 
(A) Agarose gel electrophoresis  revealed  little oligonucleosomal  DNA fragmentation compared to positive  controls cells  (THP-1 treated  with actinomycin 
D [lane  A] or high-dose staurosporine IS]). Representative  of eight experiments. (/3) However,  DNA strand breaks were readily detected in individual 
cells by nick/end labeling with TdT. Representative  of four experiments. (C) Loss of fragmented DNA from apoptotic nuclei by propidium iodide 
staining and flow cytometry,  visible  as a hypodiploid  peak in the PMA-treated  cells. (Necrotic  cells, killed by exposure to 10 mM HC1 for 4 h, showed 
a single diploid peak similar to the untreated controls, not shown). Representative of three experiments using both PMA and zymosan. 
130  Activation-induced  Macrophage Apoptosis (29).  FinaUy, activated IFN-7-type M•s  displayed the char- 
acteristic ultrastructural changes of apoptosis (43) during the 
first 2-4 h after activation, as described in Fig. 4. Subsequently, 
these cells showed progressive edema and eventual lysis con- 
sistent with secondary necrosis, which was coincident with 
the onset of positive trypan  blue staining (Fig.  2). 
Taken together,  these  findings supported  the conclusion 
that  activation-induced  cell death  in IFN-7-type  M~s oc- 
curred via apoptosis.  Since apoptosis was consistent and uni- 
form, and since secondary necrosis followed rapidly, end-point 
viability assays such as those used in Figs.  1 and 2 appeared 
reasonable measurements  of activation-induced  cell death in 
our system,  and these were used in subsequent experiments. 
Activation-induced Apoptosis Is Developmentally Regulated. 
Since the IFN-7 and MCSF M~b subtypes both derived from 
the same starting  population, we wished to determine the 
point at which differences in sensitivity to apoptosis emerged. 
We found that fresh monocytes were initially susceptible  to 
activation-induced  apoptosis,  but during differentiation  in 
rhMCSF they progressively  acquired resistance (Fig.  5 A). 
However,  if IFN-7 was present,  differentiating  monocytes 
remained sensitive to apoptosis indefinitely,  despite the pres- 
ence of rhMCSF. To exert fully this effect, IFN-7 had to be 
added early in differentiation;  if its addition was delayed it 
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Figure 4.  Ultrastructural changes of activation-induced  apoptosis. Mono- 
cytes were cultured for 4 d in rhMCSF  +  IFN-7, then exposed to PMA. 
(.4) After 2 h, there was widespread evidence of membrane blebbing (b), 
loss of cytoplasmic volume, chromatin condensation (c) with micronucle- 
ation, nuclear fragmentation  (f), and formation of apoptotic bodies (a). 
(B) By 4 h, many of the apoptotic cells (a) had begun to develop progres- 
sive cytoplasmic and nuclear edema (e), leading ultimately to secondary 
necrosis (n).  x2,750. 
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Figure 5.  Developmental regulation  of susceptibility to apoptosis. In 
all experiments, monocytes were cultured for 6 d in rhMCSF, with IFN-7 
added at various times as described. PMA was added on day 5 unless other- 
wise indicated; survival was quantitated  on day 6 by DNA content and 
expressed as percentage of controls without PMA. (,4) Cultures were ini- 
tiated in either rhMCSF alone (circles) or rhMCSF  +  IFN-7 (squares) and 
replicate  cultures activated  with PMA on each day. (IFN-7-type Mcks never 
acquired resistance to apoptosis and were not routinely assayed past day 
3, but in other experiments they remained sensitive at least to day 10, 
the limit of our assays.) (B) IFN-7 was added on successive  days and the 
cultures activated on day 5. Delayed addition of IFN-7 was progressively 
less effective at restoring cells to the fully apoptosis-sensitive state. (C) 
IFN-7 was added on day 0, then on successive  days replicate cultures were 
washed and continued in rhMCSF alone until activation on day 5 (day 
0 controls never received IFN-7). Exposure to IFN-7 for the first 24 h 
of culture was sufficient to confer long-lasting  susceptibility to apoptosis. 
(D) Dose-response  relationship for IPN-7-induced sensitivity to apop- 
tosis. Each of the above graphs is representative of three  to five similar 
experiments. Points are the mean of triplicate determinations;  SD was 
<_+10% for all points and error bars have been omitted for clarity. became progressively  less effective in maintaining uniform 
sensitivity to apoptosis (Fig. 5 B). However, even a brief ex- 
posure to IFN-T at the onset of differentiation was sufficient 
to confer sustained sensitivity to apoptosis, even if the IFN- 
3' was subsequently removed (Fig.  5 C). Thus, activation- 
induced apoptosis appeared  to be a stable, developmentally 
regulated attribute of the IFN-~/phenotype, which was de- 
termined during a critical  early period in differentiation. 
Activation-induced Apoptosis Is Selective for IFN-7-primed 
M~s.  To test for selectivity we derived MCSF-type and IFN- 
y-type M(ks in paralld cultures, then combined the popula- 
tions on day 4 and continued the cocultures in rhMCSF alone. 
(To emphasize the developmental nature of the effects under 
study, IFN-qr-type Mqbs were exposed to IFN-T only for the 
first 24 h of culture as described above). The MCSF-type M~bs 
were labeled with a stable tracking dye so that the subpopu- 
lations could be distinguished. As shown in Fig.  6, when 
mixed cocultures were activated with PMA there was a selec- 
tive and complete elimination of only those M~s with a his- 
tory of IFN-3' exposure.  These experiments supported our 
hypothesis that sensitivity to activation-induced apoptosis was 
determined by the developmental history of the individual 
Figure 7.  Comparable expression of BCL-2 in sensitive and resistant 
M~s. MOs were cultured for 4 d in rhMCSF or rhMCSF  +  IFN-3, and 
analyzed for BCI.,2 protein by direct immunofluorescence (A) or immu- 
noblot (B). Equal numbers of cells were loaded in each lane. Representa- 
tive of three experiments. 
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Selective  elimination of apoptosis-semitive  cells  in mixed cocul- 
tures. MCSF-type and IFN-~-type  MOs were derived in separate cultures. 
The MCSF-type cells were labeled with PKH26 tracking dye, mixed with 
equal numbers of IFN-3t-type cells, and the cocultures were activated with 
PMA. (A) Selective  elimination of the IFN-3,-type (PKH26-negative) M~ 
population after activation, compared to control cultures without PMA. 
Representative of three experiments. (B) Quantitative results for the ex- 
periment shown in A, based on cell counts after coculture. 
cell, rather than by the cytokine environment prevailing at 
the time of activation. 
Apoptosis Occurs  Despite  BCL2 Expression.  We compared 
expression of the antiapoptosis BCL-2 protein in sensitive and 
resistant  M(k subtypes.  As shown in Fig.  7, both subtypes 
expressed similar amounts of BCL-2 protein, whether assessed 
at the single-cell level by flow cytometry, or by immunoblot 
analysis. This level of BCL-2 expression was comparable to 
that found in resting lymphocytes (not shown). 
Apoptosis Is Not due to Accumulation of Nonspecific Toxic 
Factors.  Activated M~s can secrete toxic substances, partic- 
ularly reactive oxygen species and NO. We therefore asked 
whether scavengers of these by-products could protect against 
apoptosis.  Each of the agents chosen had been successfully 
used in other settings to protect against free radical injury 
(25, 44-47). However, we found that none of them prevented 
activation-induced apoptosis in our system (Table 1). In ad- 
dition, measured levels of hydrogen peroxide (a major reac- 
tive oxygen species secreted by Mtks) in the culture medium 
remained within a nontoxic range throughout the time that 
the cells were undergoing apoptosis  (maximum concentra- 
tion <(15/zM,  compared to a measured LDs0 for our cells 
of >100 #M,  n  =  3,  assays as described  in Materials  and 
Methods). The concentration of superoxide anion was even 
lower than that of H202  (<(5/zM). 
NO also did not appear to play a major role in our system, 
since (a) the NO synthase inhibitor arginine methyl ester did 
not protect against  apoptosis (Table 1); (b) pharmacologic 
generation of NO by 1 mM sodium nitroprusside did not 
initiate apoptosis (three experiments, not shown); and (c) as 
described in Materials and Methods, NO production was un- 
detectable  (<30 pmol/ml) in our system even after  IFN-3, 
priming and PMA triggering. Taken  together, these data sug- 
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Survival* 
Agent  Concentration*  ( -  )PMA  ( + )PMA  n s 
Catalase  5,000 U/ml  +  -  5 
Superoxide dismutase  300 U/ml  +  -  4 
N-acetylcysteine  30 mM  +  -  811 
Butyrated  hydroxyanisole  400 #M  +  -  5 
Pyrrolidine dithiocarbamate  60/~M  +  -  4 
Dihydroxybenzene-disulfonic  acid  10 mM  +  -  5 
/$-mercaptoethanol  10 mM  +  -  2 
Arginine  methyl  ester  1 mM  +  -  4 
* The highest concentration of inhibitor which was not toxic to the cells was used for all experiments. 
* Apoptosis in these experiments was uniform and unambiguous, so survival is reported simply as +  (>90% viable) or -  (<10% viable) at 24 h. 
S Number of replicate experiments. 
If In two/eight experiments with N-acetylcysteine a small number of cells in the PMA-challenged group still excluded trypan blue at 24 h. These 
cells were found on cytocentrifuge preparation to be apoptotic, and uniformly progressed to necrosis by 48 h. 
gested that nonspecific toxicity from reactive intermediates 
of oxygen and nitrogen appeared unlikely to account for apop- 
tosis in our  system. 
Role of  PKC.  PMA and zymosan have both been reported 
to activate PKC in M~s (48, 49). Preliminary experiments 
in our system had shown that 4cr  12,13 didecanoate 
(a phorbol ester which does not activate PKC) had no effect 
on apoptosis, while thymeleatoxin (which is highly selective 
for PKC [50]) triggered apoptosis indistinguishably from PMA 
(LDs0  ~10  nM,  three  experiments).  We  therefore  asked 
whether there was functional evidence of PKC activation be- 
fore apoptosis in our cells. As shown in Fig. 8 A, PMA caused 
translocation of enzymatic activity consistent with PKC from 
the soluble to the particulate fraction within 15 min of ex- 
posure. When we examined a representative isoform of PKC 
(PKC-o6 the classical isoform most abundantly expressed in 
our cells) by immunoblot analysis,  immunoreactive protein 
was also found to translocate to the particulate fraction fol- 
lowing PMA stimulation.  This translocation of PKC-c~ in- 
cluded its appearance in the nudens (Fig.  8 B), the site of 
many early changes  of apoptosis. 
To test whether activation of PKC was functionally related 
to apoptosis, we asked whether pharmacologic inhibitors of 
PKC would block PMA-induced cell death.  Because many 
PKC inhibitors are themselves lethal to living cells (51), we 
tested several compounds to identify the least toxic. Calphostin 
C,  H7,  and chelerythrine  all proved highly toxic, but the 
broad-spectrum kinase inhibitor staurosporine was well toler- 
ated in the range required  to inhibit  PKC (51).  As shown 
in Fig. 8 C, a concentration of 10 nM staurosporine was fully 
protective against PMA-induced apoptosis. Staurosporine was 
also significantly protective against zymosan-induced apop- 
tosis (Fig. 8 D), although complete protection was not achieved 
with this agonist. Taken together, our findings thus suggested 
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a possible functional role for PKC in the signaling pathway 
leading  to apoptosis in  our cells. 
Discussion 
In this study we describe a novel pathway capable of in- 
ducing rapid and selective apoptosis of a specific  subset of 
mature  Mcks after activation.  The fact that  differentiating 
monocytes became resistant to the form of apoptosis induced 
by passive cytokine withdrawal emphasizes the need for an 
inducible pathway if apoptosis is to play a role in regulating 
mature Mcks. Not all activating agents led to apoptosis:  simple 
stimuli such as purified LPS or FMLP were not lethal. How- 
ever, opsonized zymosan, a complex particulate stimulus con- 
sisting of yeast cell walls, activated complement, and serum 
proteins, triggered prompt apoptosis, perhaps due to its closer 
resemblance to physiologic M~  targets. 
The role for PKC implied by our observations was unex- 
pected, since in many systems PKC has been found to sup- 
press apoptosis rather than initiate it (reviewed in reference 
52). Recently, however, several forms of apoptosis apparently 
mediated by PKC have been described (53-55). PKC is known 
to comprise a family of related isoenzymes with different func- 
tional properties (56), and the effects of PKC activation may 
change with the developmental stage of a particular cell type 
(57) (as witness the different responses of our two M~ sub- 
types). The brief series of kinase experiments included in this 
report are intended only to support a role for PKC in initi- 
ating apoptosis in our system. A more detailed characteriza- 
tion of PKC activity in these cells will be presented elsewhere 
(Munn, D. H., A. C. BeaU, M. Mabie, and D. Throckmorton, 
manuscript  in preparation). 
Several questions regarding activation-induced Mq~ apop- 
tosis remain unanswered. The role of BCL2 is not yet dear. Figure 8.  Evidence  for PKC activation  during apoptosis. Monocytes 
were cultured for 4 d in rhMCSF + IFN-3, then activated  with PMA. 
(.4) Translocation  of Ca  2+/lipid-dependent kinase activity  from soluble 
to particulate  fraction  after  15 min exposure  to PMA. Each  point  represents 
the average (_+SD) of three separate  experiments,  normalized  to the total 
kinase  activity  (soluble + particulate)  in the control  cells for each experi- 
ment. Asterisks  indicate  significant  (p <0.01) difference  compared to the 
control values  by paired t test. (B) Translocafion  of  immunoreactive  PKC-~x 
from cytosol  to nucleus  in response to PMA. (Translocation  was also ob- 
served  if  cells  were  fractionated  into soluble  and particulate  compartments, 
not shown.) Control: rat brain cytosol  (RB).  (C) Inhibition  of PMA- 
induced apoptosis (circles)  by the kinase  inhibitor staurosporine, 20 riM, 
added 1  h before  PMA exposure (squares). Survival  measured  by DNA con- 
tent after 24 h. (D) Inhibition  of zymosan-induced  apoptosis  by 10 and 
20 nM staurosporine  (asterisks indicate  significant  differences  vs zymosan 
Quantitative differences in BCL-2 expression  apparently do 
not underlie the differences in our cells, but we have not yet 
tested for dominant regulators of  BCb2 function such as BAX 
or BCL-X (58,  59). A second question concerns the role of 
reactive oxygen and nitrogen species. IFN-q,-primed M~s pro- 
duce reactive oxygen species after activation, and oxidative 
stress can trigger apoptosis (60). Although we were unable 
to inhibit apoptosis with a variety of free-radical scavengers, 
it may be that these agents did not function effectively at 
the intracellular level. At present we cannot definitively ex- 
clude a role for intracellular  oxidative stress in M~ apoptosis. 
NO, which in mice can be produced by activated M~s, has 
also been reported to cause apoptosis (61). However, we, like 
others (see also reference 62), could not detect NO production 
in our human system despite the use of sensitive assays, nor 
did NO generated pharmacologically  from sodium nitroprus- 
side initiate apoptosis.  Thus NO seemed unlikely to partici- 
pate in our system. 
Proposed Physiologic Significance.  Conceptually, the phe- 
nomenon of activation-induced M~ death appears paradox- 
ical: why should MOs die simply because they perform their 
intended function? We speculate that this arrangement may 
confer two important benefits.  The first is to regulate the 
destructive potential of IFN-'y-primed M~s. Unlike lympho- 
cytes, which have an elaborate regulatory network to ensure 
the death of unwanted cells, and granuloeytes, which spon- 
taneously undergo apoptosis within hours of entering the 
tissues, MOs have few known mechanisms to limit their acti- 
vation. The form of apoptosis which we describe allows for 
normal activation in the short term, thus permitting the M~s 
to perform their antimicrobial function, but it strictly limits 
the subsequent persistence  of the activated cells. 
The second proposed benefit arises from the unusual na- 
ture of facultative intracellular pathogens. These highly resis- 
tant microorganisms have evolved the ability to preferentially 
survive and replicate within M~s after phagocytosis, where 
they are shielded from immune attack (3). Priming with IFN-3~ 
is intended to help M~s destroy such pathogens as they are 
ingested (4-6), but any organisms which survive possess a 
variety of strategies  to subvert their M~ host into an unin- 
tentional incubator (3, 63). The prompt death of M~s after 
they have attempted to kill such pathogens thus becomes log- 
ical if it is seen as denying surviving microorganisms their 
intended sanctuary site. 
Taken together, our data suggest a model in which naive 
monocytes "decide" during terminal differentiation whether 
or not to remain subject to activation-induced apoptosis. This 
decision is based on the cytokine milieu encountered during 
differentiation, and thus reflects the intended function, and 
also the destructive potential, of the mature M~s. 
alone  by one-way  analysis  of  variance,  p <0.01). Survival  measured  by trypan 
blue dye exclusion  after 8 h. All figures representative of at least three 
experiments with similar results. 
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